Skip to main content
. Author manuscript; available in PMC: 2024 Oct 28.
Published in final edited form as: AIDS. 2017 Mar 27;31(6):745–752. doi: 10.1097/QAD.0000000000001389

Fig. 2. Plasma viral loads and vaginal viral shedding in STI-infected TFV-treated animals.

Fig. 2.

STI, sexually transmitted infection; TFV, tenofovir. (a) Individual plasma virus load kinetics of placebo (black dotted lines) and breakthrough infection (black solid line) under continued weekly gel dosing. Time zero indicates the time of first simian HIV RNA detection in plasma. (b) Mean virus shedding in controls (closed circles) and breakthrough infection (clear squares). Arrow indicates a time of peak plasma viral load.